Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2024 May 18;35(2):102215. doi: 10.1016/j.omtn.2024.102215

Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer

Xiliu Chen, Zhongliang Wang, Fan Tong, Xiaorong Dong, Gang Wu, Ruiguang Zhang
PMCID: PMC11111815  PMID: 38784179

Main text

(Molecular Therapy: Nucleic Acids 19, 643–653; March 2020)

This article has been retracted at the request of the editor-in-chief. Concerns regarding image recycling were posted to a Pubpeer thread (https://pubpeer.com/publications/395E8AF1EA01D1FE083DB7D9FBD0AD). Similarities were found between images in this article and another article in this same journal, Molecular Therapy Nucleic Acids (Feng et al., 2019, Mol. Ther. Nucleic Acids 18, 375–387, https://doi.org/10.1016/j.omtn.2019.08.024). Image analysis performed by the editorial office confirmed the findings of image reuse with Figure 2A. This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The notice of retraction was undeliverable to all authors except for the corresponding author. No response was received from the corresponding author.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES